retatrutide diabetes More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase Effects of retatrutide, dulaglutide, and

to join a remote clinical trial that is testing whether an existing FDA-approved therapy, tirzepatide, can provide relief from long COVID symptoms

If you have questions about GLP-1 medications or want to explore your options, check out our FAQs

Monitor for excessive appetite suppression, unintended weight loss, increased heart rate or blood pressure, compounded gastrointestinal symptoms like nausea, and signs of dehydration

GLP-1 medications reduce calorie intake by increasing satiety and slowing digestion

Pharmacies typically add a markup of 1040% on top of WAC, which is why the same drug can cost different amounts at different pharmacies